Letter to our stakeholders on COVID-19 pandemic impact on AB Science studies
03/04/2020 – A letter to our stakeholders on COVID-19 pandemic impact on AB Science clinical studies
Summary of webcast with Key Opinion Leaders on masitinib Phase 2B/3 results in Progressive Forms of MS
09/03/2020 – AB Science provides a summary of the live webcast held on March 6 2020 with key opinion leaders on progressive froms of multiple sclerosis
New fundraising of EUR 12.3 million
02/03/2020 – AB Science announces a new fundraising of EUR 12.3 million
Positive top-line Phase 2B/3 results for masitinib in progressive forms of MS
20/02/2020 – AB Science announces positive top-line Phase 2B/3 results for oral masitinib in progressive forms of multiple sclerosis
FDA green-lights U.S. patient enrollment in masitinib phase 3 study in metastatic castrate-resistant prostate cancer
08/01/2020 – FDA green-lights U.S. patient enrollment in masitinib phase 3 study following IND clearance in metastatic castrate-resistant prostate cancer eligible to chemotherapy
Publication of new results in in the peer-reviewed journal Glia that further support masitinib’s potential mode of action in ALS
23/12/2019 – AB Science announces publication of new results in the peer-reviewed journal Glia that further support masitinib’s potential mode of action in ALS
Publication of three AB8939 scientific abstracts in the special ASH Annual Meeting issue of Blood
09/12/2019 – AB Science announces publication of three AB8939 scientific abstracts in the special ASH Annual Meeting issue of Blood
Webcast on masitinib in severe asthma on Monday, December 2, 2019
27/11/2019 – AB Science will host a live webcast on masitinib in severe asthma on Monday December 2, 2019
Summary of webcast with Key Opinion Leaders on Indolent Systemic Mastocytosis
25/11/2019 – AB Science provides a summary of the live webcast on November 20 with key opinion leaders on Indolent Systemic Mastocytosis (ISM)
Clarification regarding the article in the newspaper Les Echos related to the investigation by the French market authorities
22/11/2019 – AB Science provides clarification regarding the article in the newspaper Les Echos related to the investigation by the French market authorities